Stanford debuts ultracompact proton therapy system to target tumors
This image was generated by AI and may not depict real events.
Stanford Medicine is launching a compact proton therapy system to target tumors, which could mark a major shift in how tumors are treated. The system, developed by Mevion Medical Systems, can rotate and move patients into precise positions to target different areas of the body while sparing nearby tissue.
Stanford Medicine is preparing to launch a compact proton therapy system. The system delivers proton therapy, a specialized form of radiation, and can target tumors while sparing nearby tissue. It was developed by Mevion Medical Systems and is a major improvement over earlier generations of proton therapy machines. The new system is much smaller and can be used to treat patients, especially young ones, with reduced long-term side effects. Stanford's team believes the clinic will make proton therapy more accessible for lower-income families. The team expects to begin treating patients as early as this summer.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.